C-Src tyrosine Kinase (CSK) (Middle Region) Peptide
CSK
适用: 人
宿主: 合成
BP, WB
产品编号 ABIN975365
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for C-Src tyrosine Kinase (CSK) (Middle Region) Peptide (ABIN975365)
抗原
CSK
(C-Src tyrosine Kinase (CSK))
宿主
人
资源
合成
应用范围
Blocking Peptide (BP), Western Blotting (WB)
-
-
蛋白结构域
- Middle Region
-
序列
- SEDNVAKVSD FGLTKEASST QDTGKLPVKW TAPEALREKK FSTKSDVWSF
-
产品特性
- This is a synthetic peptide designed for use in combination with anti-CSK Antibody(ARP52042_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
纯化方法
- Purified
-
-
C-Src tyrosine Kinase (CSK) peptide
CSK 适用: 人, 小鼠, 大鼠, Cow, 犬 宿主: 合成 BP, Imm
-
-
应用备注
- Each Investigator should determine their own optimal working dilution for specific applications.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
浓度
- 1 mg/mL
-
缓冲液
- Final peptide concentration is 1 mg/mL in PBS.
-
注意事项
- Avoid repeated freeze-thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- CSK (C-Src tyrosine Kinase (CSK))
-
背景
-
CSK specifically phosphorylates 'Tyr-504' on LCK, which acts as a negative regulatory site.CSK can also act on the LYN and FYN kinases.
Alias Symbols: MGC117393
Protein Interaction Partner: CDH5,CSK,IGF1R,INSR,RGS16,ADRB2,ARRB1,CAV1,CD247,CD44,CDH5,CREBBP,CSK,DAB2,DOK1,DOK3,FGR,FYN,G3BP1,GJA1,GSN,HCK,HNRNPK,IGF1R,INSR,LAIR1,LCK,LYN,MAPK15,PAG1,PECAM1,PLD2,PRKACA,PTK2,PTPN12,PTPN18,PTPN22,PXN,RASA1,RGS16,SDC3,SHC1,SIT1,SRC,TLR3,ARRB1,CAV1,CBL
Protein Size: 450 -
分子量
- 51 kDa
-
基因ID
- 1445
-
NCBI登录号
- NM_004383, NP_004374
-
UniProt
- P41240
抗原
-
You are here:
